pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Podcast examines Democrats' midterm win and concerns over a costly, questionable fertility genetic procedure

Nov 6, 2026·read at STAT ↗Neutral

Stat's weekly biotech podcast "The Readout LOUD" released an episode featuring Washington correspondent Daniel Payne to discuss how the Democrats' sweeping midterm victory could shape drug pricing policy and the future of the FDA.

The conversation also explored the political landscape's potential impact on health care legislation, noting that a unified Democratic Congress may pursue more aggressive pricing reforms.

Separately, colleague Megan Molteni presented findings on a network of overseas fertility clinics promoting an expensive genetic procedure whose efficacy and safety remain in doubt, raising ethical and regulatory questions.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Democrats’ midterm victory, and a questionable fertility procedure”

read at STAT ↗
405 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2FATE THERAPEUTICS INCModerna, Inc.OVERSEAS
drugs
Obesity2
topics
Obesity2OncologyVaccinemRNA Therapeutic

related stories

  • Jul 23FDA panel confronting peptide controversySTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Alethio attains $90M series A for rare blood cancer drugsFierce Biotech
  • Oct 30Assessing Merck and Moderna’s mRNA cancer vaccineSTAT
  • Oct 2What it’s like to wait for the call from the Nobel Prize committeeSTAT
  • Sep 29STAT+: AstraZeneca invests $2 billion in Summit TherapeuticsSTAT